Bousfield George R, Butnev Vladimir Y, White William K, Hall Aaron Smalter, Harvey David J
Department of Biological Sciences, Wichita State University, Wichita, KS 67260.
Molecular Graphics and Modeling Laboratory, University of Kansas, Lawrence, KS 66045.
J Glycomics Lipidomics. 2015;5(1). doi: 10.4172/2153-0637.1000129.
Glycans from six highly purified hFSH preparations were released by peptide-N-glycanase digestion and analyzed by negative mode nano-ESI mass spectrometry before and after neuraminidase digestion. Pituitary glycan structures were mainly high-mannose, di-, tri-, and tetra-antennary, and their abundance largely paralleled that reported by other investigators using different approaches. For most of the FSH preparations, the differences in glycosylation appeared to be restricted to relative abundances of the major glycan families, as defined by their neutral core oligosaccharide structures. Qualitative differences between glycan populations were largely relegated to those species that were lowest in abundance. Significant qualitative differences were noted in two cases. Recombinant GH-hFSH triantennary glycans appeared to have the third antenna exclusively on the mannose6-branch, in contrast to all pituitary and urinary hFSH triantennary glycans, in which this antenna was exclusively attached to the mannose3-branch. The hypo-glycosylated hFSH preparation isolated from purified hLH was decorated with high mannose glycans that accounted for over 40% of the total in this population. As this preparation was found to be consistently 20-fold more active than hFSH in FSH receptor-binding assays, it appears that both macroheterogeneity and microheterogeneity in FSH preparations need to be taken into account.
通过肽-N-聚糖酶消化从六种高度纯化的人促卵泡激素(hFSH)制剂中释放聚糖,并在神经氨酸酶消化前后通过负模式纳米电喷雾质谱进行分析。垂体聚糖结构主要是高甘露糖型、二天线、三天线和四天线型,其丰度在很大程度上与其他研究者使用不同方法报道的情况相似。对于大多数FSH制剂,糖基化的差异似乎仅限于主要聚糖家族的相对丰度,这些家族由其中性核心寡糖结构定义。聚糖群体之间的定性差异在很大程度上局限于那些丰度最低的种类。在两个案例中发现了显著的定性差异。重组生长激素-hFSH三天线聚糖似乎仅在甘露糖6分支上有第三条天线,这与所有垂体和尿源性hFSH三天线聚糖相反,后者的这条天线仅连接在甘露糖3分支上。从纯化的人促黄体生成素(hLH)中分离出的低糖基化hFSH制剂带有高甘露糖聚糖,在该群体中占总量的40%以上。由于在FSH受体结合试验中发现该制剂的活性始终比hFSH高20倍,似乎FSH制剂中的宏观异质性和微观异质性都需要考虑在内。